On the other hand, potential therapeutic benefits of increasing ACE2 expression or activity using recombinant human ACE2, gene therapy, or ACE2 activators has been shown to be effective in several diseases including hypertension, heart failure, stroke, diabetes, and kidney injury [1,4,5,6]. This evidence concerns the gene ACE2 and diabetes mellitus.